In recent years, the off-label use of injectable medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) for weight loss has surged, influencing not only metabolic health but also dermatologic care. 

Originally approved for type 2 diabetes, both drugs mimic gut hormones to reduce appetite and improve insulin sensitivity—leading to significant weight reduction.Ozempic, a GLP-1 receptor agonist, gained early popularity after studies showed up to 15% body weight loss in some patients. Mounjaro, a dual GLP-1 and GIP receptor agonist, may offer even greater efficacy, with clinical trials reporting average weight losses exceeding 20%.

Apart from weight loss it can also provide other skin benefits like: . Weight loss can improve conditions like acanthosis nigricans, psoriasis, and hidradenitis suppurativa, all of which are exacerbated by obesity and insulin resistance. However, rapid weight loss may also accelerate facial volume loss, leading to increased demand for cosmetic interventions like fillers or skin-tightening procedures. And this is why it is important to start these injections under the guidance of a doctor. 

While both drugs are effective for your, the right injection for you will be decided by your doctor. 

So step into your nearest TenderSkin International clinic and start your weight loss journey today.